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Abstract. We aggregated published data from field studies documenting prevalence of Schistosoma haematobium
infection and bladder pathology determined by ultrasonography or hematuria detected by reagent strip, questionnaire,
or visual examination. A mathematical expression was used to describe the associations between prevalence of pathol-
ogy/morbidity and infection. This allows for indirect comparison of these methods, which are rarely used simultaneously.
All four methods showed a similar, marked association with infection. Surprisingly, ultrasound revealed higher preva-
lences of pathology in schools than in communities with the same prevalence of infection, implying a need for age-related
cut-off values. Reagent strip testing yielded a higher prevalence than questionnaire, which in turn was higher than by
visual examination. After correction for morbidity due to other causes, a consistent ratio in prevalence of hematuria of
3:2:1 resulted for the three respective methods. The simple questionnaire approach is not markedly inferior to the other
techniques, making it the best option for field use.
INTRODUCTION
Identification of cases or communities for treatment of in-
fection with Schistosoma haematobium is usually based on
microscopic detection of eggs in urine. Detection of hema-
turia, the main symptom of urinary schistosomiasis due to S.
haematobium infection, may be a simpler and cheaper alter-
native for identifying communities in need of treatment.1,2
Microhematuria can be detected by reagent strip testing.
Macrohematuria can be detected with the help of a question-
naire (i.e., asking individuals if they have experienced blood
in urine in a given period) or by visual examination of a urine
sample.3 Since 1970, ultrasonography has been applied to vi-
sualize lesions in the bladder wall caused by trapped S. hae-
matobium eggs.4−6 This method is not suitable for large-scale
use in control, but it is accepted as a relatively simple non-
invasive method in hospital or research settings.7
Many epidemiologic studies have been conducted to inves-
tigate the characteristics of the above methods to measure
urinary schistosomiasis. This usually involved comparing the
outcomes with infection. The four methods enumerated
above have rarely been directly compared. Moreover, most
studies concerned a single school or community or neighbor-
ing schools/communities in a defined area (district).
In this study, we aimed at evaluating four techniques for
detecting pathology or morbidity due to S. haematobium in-
fection: bladder pathology by ultrasound, microhematuria by
reagent strip, and macrohematuria by questionnaire or visual
examination. We aggregated all field studies reporting preva-
lence of infection and prevalence of pathology/morbidity. We
explored the association of each of these methods with infec-
tion over different endemicity levels. Using these associa-
tions, we were able to make an indirect comparison of the
performance of each of these four methods.
METHODS
Data collection. We searched PubMed (United States Na-
tional Library of Medicine) to identify all articles published
up to the year 2002 reporting on the prevalence of ultrasono-
graphically detectable bladder pathology, reagent strip−
detected microhematuria or macrohematuria determined by
questionnaire or by visual examination in unselected study
populations (schools or whole communities) with known
prevalence of S. haematobium infection. The references of the
collected articles were checked for additional articles and
quantitative information was extracted. Only pretreatment
data were included. Prevalence data from each community or
school were included as independent observations, i.e., one
study could contribute multiple observations to the analysis.
Data on bladder pathology were included if the pathology
had been detected by ultrasound and was defined using the
international standards,8,9 i.e., the presence of an irregular
bladder wall, a bladder wall thickness > 5 mm, the presence of
masses or presence of pseudo polyps. For microhematuria
determined by reagent strip, we used the data reported for the
1+ positive limit. Data on macrohematuria obtained by means
of the questionnaire method were included if measured by
asking participants to respond to a question such as “Have
you urinated blood during the past period” (the period varied
between studies and a maximum of four weeks was chosen).
We used the results reported for the longest period in ana-
lyzing the one study that used two recall periods (1 day and 1
week).10 Prevalence studies on visibly detected macrohema-
turia (inspection of urine samples by health workers) were
included if they scored clearly red urine as positive. Only
studies with prevalence of infection based on standard filtra-
tion of 10 mL of urine or a method with comparable sensi-
tivity were included: namely, filtration, centrifugation, or
sedimentation of 5−20-mL urine samples.11
Relating pathology or morbidity to infection. A mathemati-
cal expression was used to describe the associations between
prevalence of pathology/morbidity and prevalence of infec-
tion (Appendix 1). The lines representing the expression start
in the origin or a point higher on the y-axis (baseline level).
This is because morbidity can also be due to other causes
(e.g., microhematuria from bacterial urinary tract infection)
or misclassification (e.g., brown concentrated urine can be
reported as hematuria). Positive hematuria testing in the ab-
sence of S. haematobium infection (i.e., prevalence of infec-
tion close to zero) was considered to be a false-positive test
result. The lines are assumed to remain horizontal at low
prevalence of infection because only few or no cases have an
infection intensity high enough to cause morbidity. For higher
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prevalences, the lines rise with increasing speed as the pro-
portion with high intensity, associated with morbidity will in-
crease faster than the corresponding prevalence.12 The lines
eventually reach their maximum level somewhere below
100%. This is because morbidity can be intermittent, or some
of the infected individuals may not be susceptible for devel-
oping morbidity. Further details of the mathematical equa-
tion and its three parameters can be found in Appendix 1.
Using this methodology, we assessed the associations be-
tween prevalence of S. haematobium infection and the preva-
lence of the four diagnostic methods: ultrasonographic detec-
tion of bladder pathology, microhematuria determined by re-
agent strip testing, and macrohematuria determined by
questionnaire or by visual examination. We examined the
impact of two determinants on these associations: study set-
ting (school or community survey) and geographic area (west
Africa: Benin, Burkina Faso, Gambia, Ghana, Côte d’Ivoire,
Mali, Niger, Nigeria, Senegal, Chad; east Africa: Kenya,
Madagascar, Mozambique, Tanzania, Zambia, Zimbabwe;
and north Africa: Egypt, Ethiopia, Sudan). The fitted expres-
sions corrected for the baseline level (i.e., not taking into
account morbidity due to other causes) were used to study the
pathology or morbidity caused by S. haematobium infection.
We used the derived associations to compare the perfor-
mance of the different diagnostic methods. Finally, we pre-
dicted the consequences for community diagnosis if it were
based on detecting hematuria instead of infection. This was
done by comparing the proportions of schools and communi-
ties correctly categorized according to the World Health Or-
ganization (WHO) recommendations for mass treatment us-
ing the three methods to detect hematuria (Appendix 2).
RESULTS
We were able to make use of data from 19 studies contain-
ing information from 16 schools and 16 communities to esti-
mate the association between prevalence of S. haematobium
infection and bladder pathology by ultrasound.13−31 The
prevalence of bladder pathology was clearly found to increase
with the prevalence of infection (Figure 1a). Prevalences from
school surveys were generally higher than from community
surveys with a comparable prevalence of infection, as dem-
onstrated by both a difference in baseline prevalence and a
stronger association with infection. The calculated baseline
prevalence was 13% for schools and 3% for community sur-
veys. Apparently, school children have more bladder pathol-
ogy due to other causes or are more often misclassified by
ultrasound. The lines finally reached 79% for school children
and 59% for communities. Pathology prevalences were some-
what higher in west Africa compared with north Africa, but
this is partly explained by the fact that the latter mainly con-
cerned community studies.
Data from 45 studies comprising 74 schools and 28 com-
munities was available to evaluate the prevalence of micro-
hematuria detected by reagent strip testing.10,15,19,22−25,28,30−66
Again, the prevalence of hematuria increased markedly with
the prevalence of infection (Figure 1b). Separate analysis for
schools and communities showed a slightly lower baseline
prevalence of microhematuria (reagent strip) for schools
(24% versus 16%); however, the lines largely overlapped and
both ultimately reached 77% for higher endemicity levels.
The lower baseline prevalence for schools was mainly caused
by one study contributing 25 observations to the analysis. The
same study was also responsible for a slightly lower baseline
prevalence rate in east Africa.
Twenty-one studies, comprising 117 schools and
14 communities, presented information on macro-
hematur ia that had been obtained by quest ion-
naire.1,2,10,15,17,19,20,23−25,28,30,35,38,50,54,58,59,65,67−69 Schools
and communities showed virtually identical associations of
self-reported macrohematuria rates with the prevalence of
infection (Figure 1c). The fitted associations started at a base-
line prevalence of approximately 12% and finally reached
60%. The majority of data points (80%) came from two stud-
ies in Tanzania.1,2 These studies did not unduly influence the
results because associations separately fitted for each study
did not markedly differ from each other, nor from that of the
other 19 studies.
The association between prevalence of infection and mac-
rohematuria detected by visual examination was derived
from 14 articles concerning 16 schools and 31 communi-
ties.28,31,33,38,50,59,60,65,70−75 School surveys and community
surveys with a low prevalence of S. haematobium infection
reported no cases of macrohematuria, yielding a baseline
prevalence of 0.0% (Figure 1d). Overall, the prevalence of
macrohematuria by visual examination was markedly lower
than for the other diagnostic methods. The lines for schools
and communities initially overlapped and slightly diverged for
higher prevalences. Geographic area nor study setting influ-
enced the association between infection and visibly detected
macrohematuria.
The associations in Figure 1 between prevalence of infec-
tion and bladder pathology and hematuria were summarized
(Figure 2a). Since no significant difference was found be-
tween the associations for hematuria in school children and
communities, these were combined (P > 0.20 by covariance
analysis for all three methods). At all levels of infection, the
prevalences estimated by each of the three methods did not
vary in terms of order: microhematuria (detected by reagent
strip screening) showed the highest prevalence, followed by
macrohematuria determined by questionnaire, and lastly,
macrohematuria detected by visual examination. After cor-
recting for baseline, i.e., morbidity due to other causes (false-
positive results), a proportional hematuria detection rate was
found, corresponding with a ratio of approximately 3:2:1 for
these three methods over all prevalence of infection levels
(Figure 2b). For example, at a 50% level of infection, the
corresponding prevalence of hematuria due to S. haemato-
bium infection was 38% for detection by reagent strip testing,
24% when using the questionnaire approach, and 12% using
the visual examination method. The associations of infection
and bladder pathology for schools and communities were also
proportional to those of hematuria, with bladder pathology in
schoolchildren 15% above and bladder pathology in commu-
nities 25% below microhematuria. Thus, studies in commu-
nities showed approximately 35% less bladder pathology due
to S. haematobium than studies in school children with the
same prevalence of infection (Figure 2b).
DISCUSSION
It is reassuring to have been able to demonstrate that the
four methods used to detect pathology or morbidity due to S.
haematobium all showed a clear and consistent association
with prevalence of infection. Also, in line with expectations,
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the prevalence of microhematuria determined by reagent
strip testing was higher than that of macrohematuria reported
by questionnaire, which in turn was higher than the preva-
lence of visibly detected macrohematuria. Furthermore, the
fact that previous studies that explored associations between
prevalence of infection and hematuria measured by reagent
strip,60,76 questionnaire,1,77 or visual examination75 found
patterns similar to the current study, in which all available
observations from the different field studies and geographic
areas were aggregated.
Our methodology offers a closer look at the test character-
istics of the different diagnostic techniques and their (bio-
logic) relationships (Figure 2). The baseline levels (parameter
a in the equation) of the estimated associations correspond to
a universal proportion of false-positive results, i.e., those
showing positive test results due to misclassification or other
diseases/infections than S. haematobium. In our methodology,
this proportion resulted from studies in populations not in-
fected with S. haematobium or with low endemicity. We be-
lieve this approach to be superior to the common method of
using the presence or absence of detected infection in indi-
viduals as a gold standard. In such studies, only a limited
amount of urine (1−3 repeated standard 10-mL urine filtra-
tions2,28,45,48,52,55,68,78) is usually used, so that many cases tend
to go undiagnosed. This results in an overestimation of false-
positive test results and thus also in an underestimation of the
specificity of the test.79 In our study, the specificity of the
different diagnostic techniques simply follows from a 100%
baseline prevalence: e.g., for hematuria, the specificity is 82%
for screening by reagent strip, 88% for the questionnaire
method, and 100% for the visual examination method. The
sensitivity is unable to be directly determined by our meth-
odology because the number of individuals with blood in their
urine due to S. haematobium infection that goes undetected is
unknown (false-negative results). However, the proportional
differences between the associations in Figure 2b provide
FIGURE 1. Observed associations between Schistosoma haematobium infection and clinical consequences. Prevalence of a, bladder pathology
by ultrasound; b, microhematuria by reagent strip; c, macrohematuria by questionnaire; and d, macrohematuria by visual examination as a
function of prevalence of S. haematobium infection. Observations come from published studies and concern schools (dots) or whole communities
(circles). The lines are based on equation 1 and represent schools (continuous lines) or communities (dashed lines). Parameters for bladder
pathology are a 0.13, b 3.13, and c 2.04 (schools) and a 0.033, b 1.35, and c 1.78 (communities). Parameters for microhematuria
detected by reagent strip testing are a 0.16, b 2.90, and c 2.14 (schools) and a 0.24, b 2.09, and c 2.37 (communities). Parameters
for macrohematuria detected by the questionnaire approach are a 0.13, b 1.17, and c 1.91 (schools) and a 0.11, b 1.12, and c 1.88
(communities). Parameters for macrohematuria detected by visual examination are a  0.00, b  0.38, and c  1.50 (schools) and a  0.00,
b  0.75, and c  2.50 (communities). The interpretation of parameter values is given in Appendix 1.
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some indication of how many cases are at least missed by the
respective techniques.
We assumed that the baseline prevalences do not depend
on endemicity. This may be an oversimplification because
infectious diseases tend to cluster.80 For example, the risk of
both schistosomiasis and urinary tract infection (also respon-
sible for hematuria) will probably be higher in environments
with no sanitary facilities available. Also, individuals living in
the poorest rural areas are likely to have nutritional deficien-
cies, making them more susceptible to any disease. While the
clustering of disease may have resulted in somewhat steeper
lines, the relationship between the different associations will
not have been seriously affected. The proportion of false-
positive test results due to misclassification is not likely to be
associated with the prevalence of schistosome infection.
After correcting for false-positive results, the prevalence of
ultrasound-detected pathology in school children appeared to
be largely parallel (always about 10% lower) to that of infec-
tion. As stated earlier, many infected cases are missed by
standard parasitologic screening and are not included in the
prevalence of infection. Therefore, more than a fixed 10% of
the children will be infected with S. haematobium infection,
but will have no ultrasound-detectable pathology. Neverthe-
less, a 10% prevalence of (detected) infection means that
hardly any cases with an infection intensity high enough to
show S. haematobium-related pathology will occur, whereas
an 80% prevalence of infection (and a probable 100% infec-
tion rate) causes this percentage to increase to 70%. This
clearly demonstrates the impact of increasing intensity of in-
fection (and risk of developing disease) with increasing preva-
lence of infection.
Surprisingly, the prevalence of bladder pathology mea-
sured by ultrasonography was considerably lower in commu-
nities than in school children with the same prevalence of
infection. Children showed both more false-positive results
(higher baseline prevalence in Figure 2a) and a stronger as-
sociation with infection (Figure 2b). The difference between
adults and children are in actual fact likely to be even larger
because community observations also include children. As-
suming that children make up 50% of a community, the line
for communities is expected to be located somewhere halfway
between schoolchildren and adults. The large difference in
baseline prevalence for schoolchildren (13%) and communi-
ties (3%) would appear to suggest that false-positive ultra-
sound results do not occur in adults. However, the baseline
level for communities was disproportionately determined by
six observations from a series of publications from one study
in Egypt.23−27,30 This extensive study, which reported rela-
tively low prevalences of bladder pathology in situations of
low endemicity, may have resulted in some underestimation
of the rate of false-positive results, but it could only account
for half of the difference between studies on children and
communities. Thus, misclassification or false-positive results
due to other diseases such as urinary tract infections and ure-
thral stenosis seem to be substantially more prevalent in chil-
dren than adults. It is not clear why this should be the case.
Our finding that approximately 35% less S. haematobium-
related bladder pathology was found in community studies
than in studies in school children, given the same prevalence
of infection, may also have been subject to bias, in particular
because the number of observations was rather low. How-
ever, in areas of moderate to high endemicity, almost consis-
tently lower prevalences were seen in community studies than
in studies of school children (Figure 1a). Other studies cor-
roborate the finding that lower rates of ultrasonographically
detected bladder pathology are seen in adults than in chil-
dren. In the four studies where observations for children and
adults were reported separately,13,14,17,19 prevalences of pa-
FIGURE 2. Predicted associations between Schistosoma haemato-
bium infection and prevalences of bladder pathology (thin lines),
microhematuria by reagent strip (thick continuous lines), and mac-
rohematuria by questionnaire (thick evenly dashed lines), or visual
examination of a urine sample (thick long-short dashed lines) using
the original lines from Figure 1 (a) and after correction for baseline
prevalence of morbidity or pathology due to other causes or misclas-
sification (b). Separate associations are given for bladder pathology
in schoolchildren (thin continuous line) and whole communities (thin
dashed line) (see Figure 1 for parameter values). Combined lines are
given for hematuria, with parameters a  0.18, b  2.53, and c 
2.07 (reagent strip), a 0.12, b 1.17, and c 1.90 (questionnaire),
and a 0.00, b 0.56, and c 2.11 (visual examination). At a 50%
prevalence of infection, the corresponding prevalences of hematuria
corrected for baseline morbidity are indicated by the squares.
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thology in children were always considerably higher than in
adults, even after correction for false-positive results and the
difference in prevalence of infection. Moreover, the study by
Heurtier and others,13 which was the only one that presented
prevalences of bladder pathology for different ages and egg
count groups, reported a prevalence of 77% in 70 children
with 1−99 eggs/10 mL of urine versus 62% in 68 adults of the
same egg count group (P 0.05). The difference in presence
of (ultrasound detected) bladder pathology between children
and adults could be explained by a more potent immune re-
sponse in children. However, our results on hematuria were
very consistent in showing equal levels of morbidity for chil-
dren and communities (and thus adults). Since hematuria re-
sults from the same mechanism, i.e., bladder lesions from eggs
that get trapped in the bladder mucosa,34,69 we would expect
equal levels of pathology for children and adults with the
same prevalence of infection. Thus, the most plausible expla-
nation is that ultrasound leaves a considerable number of
adults with bladder pathology undetected. Apart from those
with S. haematobium-related bladder pathology, this could
also concern cases with pathology from other diseases (false-
positive results). One explanation would be that the interna-
tionally agreed standards to define bladder pathology by ul-
trasound8,9 cannot simply be used irrespective of age. It may
be better to have criteria for children and adults separately.
In accordance with the general characteristics of the three
methods used to detect hematuria, reagent strip testing had a
higher baseline prevalence and stronger association with in-
fection compared with macrohematuria established by the
questionnaire approach, and by visual examination. First, oc-
cult blood in urine can be detected with the help of reagent
strips (high sensitivity for detection of hematuria, i.e., >5
erythrocytes/L81,82), yet it will not be reported nor detected
by visual examination. The latter methods are thought to se-
lect cases with relatively heavy infection and more severe
pathology.60 Second, hematuria due to S. haematobium infec-
tion is transitory,83,84 implying that macrohematuria has a
higher chance of being detected via the questionnaire method
than after visual examination of a single urine sample. Given
a detection ratio of 2:1 (Figure 2b), at least 50% of macrohe-
maturia cases will be missed when relying solely on a visual
examination. All cases with macrohematuria detected by ei-
ther visual examination or questionnaires that are truly at-
tributable to S. haematobium infection will in all likelihood
yield a positive reagent strip test result. It is therefore not
likely that questionnaires or visual examination of a urine
sample will add to the information derived from the reagent
strip results. The one study that presented individual results
by reagent strip and questionnaire showed that only 10 of 133
individuals who had negative reagent strip test results re-
ported having hematuria.58 This small proportion (7.5%) can
easily be explained by the rate of false-positive results ob-
served in our study. False reports of blood in urine easily
result, especially when brown, concentrated urine is mistaken
for blood, a mistake that is far less likely to occur during
visual examination of a urine sample, a procedure that is
normally performed by a trained health worker. Conversely,
the questionnaire method may also underdiagnose hematuria
because individuals may consider blood in urine as a venereal
disease and feel ashamed,85 or forget recent episodes of he-
maturia, especially in areas where blood in urine is not con-
sidered a problem.86,87 However, in the light of the fact that
50% more truly positive cases are detected by reagent strip
screening (given the ratio of 3:2 in Figure 2b), most of whom
will not have gross hematuria, this underdiagnosis is not ex-
pected to pose problems. Regarding the possibility of recall
bias, it is also interesting to note that length of the recall
period used in the studies included (usually two or four
weeks) proved to be of no importance.88 The proportion of
positive reagent strips not attributable to S. haematobium is
even higher than the proportion of false-positive results by
questionnaire. This is because other (medical) causes such as
urinary tract infections, sexually transmitted diseases, and
menstruation mainly result in very small quantities of blood in
the urine, usually not visible to the eye. These causes may be
more prevalent in adults than in children,89,90 thereby ex-
plaining the difference in baseline levels between communi-
ties and schoolchildren (24% versus 16%). However, this dif-
ference is not significant and disappears at higher endemicity
levels (prevalence of infection >20%). Ultimately, in choosing
between the three methods for detecting hematuria, the ob-
jectives of the research or control program and the resources
available are decisive. Many false-positive results will lead to
unnecessary treatment of cases with no (or low) infections
and consequently high drug cost, whereas many false-
negative results will limit the effect of the intervention. The
questionnaire method may sometimes be favorable because it
requires fewer materials and personnel training than does the
use of reagent strips or the visual examination approach.
We were also able to evaluate the performance of the three
hematuria detection techniques for categorizing communities
in the WHO recommended treatment strategies91 with the
help of our database. The probability of identifying commu-
nities below or above the cut-off values of 20% and 50%
prevalence of infection with S. haematobium was comparable
between the three hematuria detection methods (Appendix
2). Approximately 50−80% of communities and schools
would remain in the same category as when using the WHO
recommended cut-off values based on infection. Only three
schools would be seriously misclassified by visual examination
of a urine sample, i.e., no treatment instead of mass treatment
of the entire population. Given the practical advantages of the
questionnaire method, we consider it the best alternative to
infection for cheap and simple identification of communities
in need of treatment.
In conclusion, 1) the detection methods for clinical pathol-
ogy and morbidity show marked associations with prevalence
of S. haematobium infection; 2) ultrasound detects fewer
cases with bladder pathology in adults compared with chil-
dren with the same degree of pathology; 3) after correction
for false-positive results, prevalences of hematuria due to S.
haematobium are almost proportional, with a ratio of reagent
strip:questionnaire:visual examination of 3:2:1; 4) since the
questionnaire method does not have test characteristics mark-
edly inferior to the other diagnostic techniques, its advantage
in terms of required cost, time, and personnel will usually
make it the method of choice for both individual and com-
munity diagnosis; and 5) our methodology can also be applied
for other infectious diseases, particularly those in which de-
velopment of disease depends on the intensity of infection.
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APPENDIX 1
For a given school or community, we assume a prevalence
(%) of pathology or morbidity Y to be a function of preva-
lence (%) of infection X according to
Y100 = a + b X100c1 + b X100c (1)
with baseline parameter a (0  a < 1) and shape parameters
b (b > 0) and c (c > 1). The equation has a first derivative that
equals zero at X  0% and Y  a  100%. This guarantees
that at very low prevalences of infection, no or only limited
detectable morbidity is assumed to be due to Schistosoma
haematobium. Y  a  100% is the baseline prevalence of
pathology or morbidity, i.e., pathology or morbidity caused by
misclassification or other diseases (false positives). Thereaf-
ter, the line rises monotonously and finally reaches a preva-
lence of morbidity below Y 100%. The shape of the line is
determined by parameters b and c in combination. By taking
parameter a 0 (no baseline), the equation represents mor-
bidity due to S. haematobium infection corrected for morbid-
ity due to other causes. Further details are described in Van
der Werf and others.92,93
We used Systat version 3.0 (Systat Software, Inc., Rich-
mond, CA) to estimate the values of parameters a, b, and c by
fitting the equation to all n observations. The fit was deter-
mined by assuming a binomial distribution for each observa-
tion i (i 1, …, n), without assigning weight according to size
of the population. The latter assumption can easily be made
since the vertical location is determined by many more phe-
nomena (e.g., the community base-line morbidity) than the
size of the population alone. The number of individuals com-
prising one observation was usually about 100, with a mini-
mum of 32. To explore potential bias due to overrepresenta-
tion of large studies (contributing many observations), we
have re-analyzed all associations with attributing weight to
observations according to the reciprocal of the square root of
the number of observations coming from each study. For in-
stance, observations from a study contributing 16 schools or
communities had a weight of 1/4 compared with observations
from studies contributing one school or community. This ap-
proach did not lead to significantly different results and we
therefore only reported the standard procedure based on as-
sociations without attributing weight according to study size.
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Some adjustments were necessary to apply our methodol-
ogy. For micro-hematuria detected by reagent strip (associa-
tion for community) and macro-hematuria detected by ques-
tionnaire, fitting Equation 1 yielded a biologically unrealistic
trend indicated by a sharp increase of morbidity at low preva-
lence of infection and a point of inflexion at prevalence of
infection X < 25%. For both situations, we reduced the num-
ber of parameters by pre-setting the point of inflection at
prevalence of infection X 50%, which corresponds to b
[(c – 1) / (c + 1)] 2c. One study 94 with many outlier observa-
tions and one outlier observation from the study by Lengeler
and others1 (prevalence of S. haematobium infection  23%
and prevalence of macro-hematuria by questionnaire 64%)
were excluded from the analysis.
APPENDIX 2
The World Health Organization recommends no treatment
(apart from those found positive at the screening) if the
prevalence of Schistosoma haematobium infection is 20%,
mass treatment of the 5–19-year-old age group (20–50%), and
mass treatment of the whole community (>50%).91 The
prevalence of hematuria may provide a better (rapid, simple,
and cheap) method for community diagnosis.95 Some have
used the same cut-off levels of 20% and 50% for hematuria by
reagent strip.96 It may be better to use cut-off prevalences
corresponding to the values for infection. From Figure 2a, it
follows that these prevalences are 25% and 49% for reagent
strip, 17% and 33% for questionnaire, and 2% and 12% for
visual examination.
For each data point (community or school) in our database,
we assessed whether the same treatment strategy would fol-
low from using cut-off levels for hematuria compared with
infection. To prevent dependency, the cut-off levels for he-
maturia for each data point were determined after re-fitting
the associations of Figure 2a excluding this data point. Table
1 shows the proportion of schools and communities correctly
categorized for all three methods detecting hematuria. The
overall performance of the three methods did not significantly
differ (P > 0.3, by chi-square test). Only for visual examina-
tion of a urine sample, a number of schools (3) would be
seriously misclassified, i.e., receiving no treatment instead of
mass treatment of the whole community.
TABLE 1
Recommended treatment strategy based on prevalence
of hematuria*






Reagent strips 78 (61–95) 46 (30–63) 79 (66–92)
Questionnaire 64 (50–78) 47 (32–62) 78 (66–90)
Visual examination 100 (48–100) 61 (41–81) 74 (54–94)
* Values indicate the percentage (%) of schools and communities that would be correctly
categorized using cut-off prevalences for hematuria instead of the World Health Organiza-
tion recommended prevalence categories for Schistosoma haematobium infection. Shown are
no treatment (apart from those found positive at the screening) if the prevalence of infection
was 20%, mass treatment of the 5–19-year old age group (20–50%), and mass treatment of
the whole community (> 50%).91 Cut-off prevalences for hematuria corresponding to 20%
and 50% infection from Figure 2a were 25% and 49% for reagent strips, 17% and 33% for
questionnaires, and 2% and 12% for visual examination, respectively. Values in parentheses
are the 95% confidence intervals.
VAN DER WERF AND DE VLAS106
